Cannabis withdrawal and sleep: A systematic review of human studies

References

• United Nations Office on Drugs and Crime. World Drug Report 2013. New York: United Nations Publication; 2013.
   Google Scholar
• Hall W, Degenhardt L. The adverse health effects of chronic cannabis use. Drug Test Anal. 2014;6:39–45.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19:233–238.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: American Psychiatric Association; 1994.
   Google Scholar
• Wu LT, Woody GE, Yang C, Pan JJ, Reeve BB, Blazer DG. A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults. Int J Methods Psychiatr Res. 2012;21:117–133.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Pergadia ML, Lynskey MT. Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? Am J Addict. 2008;17:199–208.
   PubMed Web of Science ®Google Scholar
• Compton WM, Saha TD, Conway KP, Grant BF. The role of cannabis use within a dimensional approach to cannabis use disorders. Drug Alcohol Depend. 2009;100:221–227.
   PubMed Web of Science ®Google Scholar
• Gillespie NA, Neale MC, Prescott CA, Aggen SH, Kendler KS. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction. 2007;102:920–930.
   PubMed Web of Science ®Google Scholar
• Hartman CA, Gelhorn H, Crowley TJ, et al. Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. J Am Acad Child Adolesc Psychiatry. 2008;47:165–173.
   PubMed Web of Science ®Google Scholar
• Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170:834–851.
   PubMed Web of Science ®Google Scholar
• Piontek D, Kraus L, Legleye S, Buhringer G. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. Addiction. 2011;106:1137–1145.
   PubMed Web of Science ®Google Scholar
• Budney AJ. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Addiction. 2006;101(Suppl 1):125–133.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
   Google Scholar
• Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–129.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry. 2008;69:1354–1363.
   PubMed Web of Science ®Google Scholar
• Levin KH, Copersino ML, Heishman SJ, et al. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend. 2010;111:120–127.
   PubMed Web of Science ®Google Scholar
• Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz K, Smith TL. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 1996;91:1469–1478.
   PubMed Web of Science ®Google Scholar
• Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jorgensen P. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict. 2007;16:461–467.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat. 2008;35:362–368.
   PubMed Web of Science ®Google Scholar
• Copersino ML, Boyd SJ, Tashkin DP, et al. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006;15:8–14.
   PubMed Web of Science ®Google Scholar
• Cornelius JR, Chung T, Martin C, Wood DS, Clark DB. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav. 2008;33:1500–1505.
   PubMed Web of Science ®Google Scholar
• Dawes GM, Sitharthan T, Conigrave KM, Phung N, Weltman M. Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities. J Subst Use. 2011;16:392–405.
   Web of Science ®Google Scholar
• Ehlers CL, Gizer IR, Vieten C, et al. Cannabis dependence in the San Francisco family study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Addict Behav. 2010;35:102–110.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lea T, Copeland J. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. J Psychopharmacol. 2009;23:84–93.
   PubMed Web of Science ®Google Scholar
• Vandrey R, Budney A, Moore B, Hughes J. A cross-study comparison of cannabis and tobacco withdrawal. Am J Addict. 2005;14:54–63.
   PubMed Web of Science ®Google Scholar
• Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med Rev. 2014;18:477–487.
   PubMed Web of Science ®Google Scholar
• Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoact Drugs. 2011;43:128–135.
   PubMed Web of Science ®Google Scholar
• Tringale R, Jensen C. Cannabis and insomnia. Depression. 2011;4:0–68.
   Google Scholar
• Schofield D, Tennant C, Nash L, et al. Reasons for cannabis use in psychosis. Aust N Z J Psychiatry. 2006;40:570–574.
   PubMed Web of Science ®Google Scholar
• Glozier N, Martiniuk A, Patton G, et al. Short sleep duration in prevalent and persistent psychological distress in young adults: the DRIVE study. Sleep. 2010;33:1139–1145.
   PubMed Web of Science ®Google Scholar
• Freeman D, Brugha T, Meltzer H, Jenkins R, Stahl D, Bebbington P. Persecutory ideation and insomnia: findings from the second British national survey of psychiatric morbidity. J Psychiatr Res. 2010;44:1021–1026.
   PubMed Web of Science ®Google Scholar
• Wong MM, Brower KJ, Zucker RA. Childhood sleep problems, early onset of substance use and behavioral problems in adolescence. Sleep Med. 2009;10:787–796.
   PubMed Web of Science ®Google Scholar
• Mednick SC, Christakis NA, Fowler JH. The spread of sleep loss influences drug use in adolescent social networks. PLoS ONE. 2010;5:e9775.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009; 6(6): e1000097. doi:10.1371/journal.pmed1000097
   Google Scholar
• Vandrey R, Budney AJ, Kamon JL, Stanger C. Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend. 2005;78:205–210.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393–402.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999;94:1311–1322.
   PubMed Web of Science ®Google Scholar
• Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013;38:1557–1565.
   PubMed Web of Science ®Google Scholar
• Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013;128:64–70.
   PubMed Web of Science ®Google Scholar
• Vandrey R, Smith M, McCann U, Budney A, Curran E. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend. 2011;117:38–44.
   PubMed Web of Science ®Google Scholar
• Vandrey R, Budney A, Hughes J, Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend. 2008;92:48–54.
   PubMed Web of Science ®Google Scholar
• Pranikoff K, Karacan I, Larson EA, Williams RL, Thornby JI, Hursch CJ. Effects of marijuana smoking on the sleep EEG. Preliminary studies. J Fla Med Assoc. 1973;60:28–31.
   Google Scholar
• Penetar DM, Looby AR, Ryan ET, Maywalt MA, Lukas SE. Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot study. J Subst Abuse Res Treat. 2012;6:63–71.
   PubMedGoogle Scholar
• Milin R, Manion I, Dare G, Walker S. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. J Am Acad Child Adolesc. 2008;47:174–179.
   PubMed Web of Science ®Google Scholar
• McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology. 2012;220:309–318.
   PubMed Web of Science ®Google Scholar
• Mathers DC, Ghodse AH. Cannabis and psychotic illness. Br J Psychiatry. 1992;161:648–653.
   PubMed Web of Science ®Google Scholar
• Jones RT, Benowitz N, Bachman J. Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci. 1976;282:221–239.
   PubMed Web of Science ®Google Scholar
• Haney M, Bedi G, Cooper ZD, et al. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry. 2013;73:242–248.
   PubMed Web of Science ®Google Scholar
• Haney M, Hart CL, Vosburg SK, et al. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 2010;211:233–244.
   PubMed Web of Science ®Google Scholar
• Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Foltin RW. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 2008;197:157–168.
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology. 1999;141:385–394.
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology. 1999;141:395–404.
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW. Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology. 2001;155:171–179.
   PubMed Web of Science ®Google Scholar
• Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addict Biol. 2013;18:993–1002.
   PubMed Web of Science ®Google Scholar
• Cohen-Zion M, Drummond SP, Padula CB, et al. Sleep architecture in adolescent marijuana and alcohol users during acute and extended abstinence. Addict Behav. 2009;34:976–979.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry. 2001;58:917–924.
   PubMed Web of Science ®Google Scholar
• Bolla KI, Lesage SR, Gamaldo CE, et al. Sleep disturbance in heavy marijuana users. Sleep. 2008;31:901–908.
   PubMed Web of Science ®Google Scholar
• Bolla KI, Lesage SR, Gamaldo CE, et al. Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med. 2010;11:882–889.
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. The Cochrane Collaboration's tool for assessing risk of bias. In: Higgins JPT, Green S, ed. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5.1.0. Oxford, UK: The Cochrane Collaboration; updated March 2011. Available at www.cochrane-handbook.org. Accessed January 29, 2014.
   Google Scholar
• The Cochrane Collaboration. Cochrane Effective Practice and Organisation of Care Review Group: Data collection checklist. The Cochrane Collaboration. Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf. Published 2009. Accessed January 29, 2014.
   Google Scholar
• Viswanathan M, Ansari MT, Berkman ND, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Agency for Healthcare Research and Quality, ed. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 12-EHC047-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
   Google Scholar